Table 1. Baseline data of treatment and control groups .
| Variable | Treatment group | Control group | P value |
| Age (years) | 51.16 ± 12.84 | 52.85 ± 12.33 | 0.67 |
| Sex | 0.91 | ||
| Male | 11 | 11 | |
| Female | 10 | 11 | |
| Duration of ESRD (years) | 2.92 ± 1.91 | 4.08 ± 2.02 | 0.076 |
| Serum ferritin (µg/dL) | 432.37 ± 108.13 | 331.50 ± 167.6 | 0.98 |
| iPTH (ρg/dL) | 187.37 ± 96.93 | 164.5 ± 84.64 | 0.58 |
| Hb (g/dL) | 9.33 ± 1.25 | 9.73 ± 1.10 | 0.28 |
| Hct (%) | 28.08 ± 3.88 | 29.45 ± 3.76 | 0.27 |
| Albumin (g/dL) | 4.12 ± 0.37 | 3.79 ± 0.51 | 0.69 |
| Quantitative CRP (mg/dL) | 16.2 ± 12.86 | 9.54 ± 7.08 | 0.051 |
| Kt/V | 1.76 ± 0.18 | 1.53 ± 0.20 | 0.17 |
Abbreviations: ESRD, end-stage renal disease; CRP, C-reactive protein; Hb, hemoglobin; Hct, hematocrit; iPTH, intact parathyroid hormone.